Yusa Kazuyuki, Yamanouchi Hideyuki, Sugano Ayako, Iino Mitsuyoshi
Department of Dentistry, Oral and Maxillofacial, Plastic and Reconstructive Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan.
Department of Dentistry and Oral Surgery, Shinjo Tokushukai Hospital, Yamagata, Japan.
Case Rep Oncol Med. 2017;2017:4537631. doi: 10.1155/2017/4537631. Epub 2017 Jul 18.
This case report describes an 86-year-old woman with dormant right buccal squamous cell carcinoma who was able to maintain a reasonable quality of life after being treated with oral low-dose S-1 (80 mg/day). The treatment regimen started in April 2014 and consisted of two weeks of S-1 followed by a one-week interval. The patient remains on this regimen while maintaining her quality of life and she has been under follow-up as an outpatient for 36 months. The outcomes for this patient indicated that low-dose S-1 is a valid anticancer therapy that may help maintain quality of life for some patients with incurable or dormant cancers.
本病例报告描述了一名86岁患有静止性右颊部鳞状细胞癌的女性，在接受口服低剂量S-1（80毫克/天）治疗后能够维持合理的生活质量。治疗方案于2014年4月开始，包括服用两周S-1，随后间隔一周。患者一直采用该方案，同时维持其生活质量，并且作为门诊患者接受了36个月的随访。该患者的治疗结果表明，低剂量S-1是一种有效的抗癌疗法，可能有助于一些患有无法治愈或静止性癌症的患者维持生活质量。
